Neoral is a commercial drug used to prevent organ rejection after a transplant surgery. Its spelling is based on the word "cyclosporine", which is the active ingredient in the product. The IPA phonetic transcription of Neoral is /niːɔːrəl/, where the first syllable "nee" rhymes with "key", the second syllable "or" is pronounced like "ore", and the final syllable "al" sounds like "all". The spelling Neoral is a trademark name created by the manufacturer, Novartis, to distinguish its product from others in the market.
Neoral is a brand name for a medication containing the active ingredient cyclosporine. Cyclosporine is an immunosuppressant drug used to prevent organ rejection following transplantation, particularly in kidney, liver, and heart transplants. It belongs to a class of drugs known as calcineurin inhibitors and works by decreasing the activity of the immune system, helping to prevent the body's defense mechanisms from attacking and rejecting transplanted organs.
Neoral is available in capsule and oral solution forms and is typically taken once or twice daily. It is important to take the medication consistently and at the same time each day to maintain optimal blood levels. The dosage is tailored to each individual based on various factors, such as weight, medical condition, and response to treatment.
Like any medication, Neoral may cause side effects, including high blood pressure, kidney damage, tremors, headache, and increased susceptibility to infections. Therefore, regular monitoring of blood pressure, kidney function, and blood levels of cyclosporine is crucial during treatment.
As an immunosuppressant, Neoral requires close medical supervision and should only be used under the guidance of a healthcare professional experienced in the use of transplant medications. It is crucial to follow the prescribed dosage instructions and communicate any concerns or adverse effects to the prescribing doctor.
The word "Neoral" is a brand name for the medication Cyclosporine, an immunosuppressant drug commonly used in organ transplant patients. The term "Neoral" does not have a specific etymology in the traditional sense, as it is a proprietary name created by the pharmaceutical company Novartis, the manufacturer of Cyclosporine. The "Neo-" prefix in Neoral could imply something new or advanced, suggesting an improvement or innovation over previous forms or versions of Cyclosporine. However, it is important to note that this is speculation and not rooted in any official etymology.